Published in Clin Exp Immunol on September 01, 1985
Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA. Clin Exp Immunol (1986) 1.14
Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect. Ann Surg (1992) 0.99
Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol (1992) 0.88
Immune status and response to immunization with polysaccharide vaccines of a healthy, congenitally asplenic woman. Clin Exp Immunol (1989) 0.88
The influence of genetic factors on the immune response as judged by pneumococcal vaccination of mono- and dizygotic Caucasian twins. Clin Exp Immunol (1993) 0.85
Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria. Clin Diagn Lab Immunol (1997) 0.81
The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteria. Int J Exp Pathol (1990) 0.79
Development of anti-polysaccharide antibodies in asplenic children. Clin Exp Immunol (1986) 0.77
Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med (1981) 6.45
Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg (1952) 6.45
Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry (1972) 4.26
Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med (1977) 4.22
THE IMPORTANCE OF THE SPLEEN IN RESISTANCE TO INFECTION. Ann Surg (1919) 4.14
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med (1980) 3.95
Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate. Biochem J (1968) 3.94
Monoclonal antibodies (McAbs) to determinants on human gamma chains: properties of antibodies showing subclass restriction or subclass specificity. Immunology (1982) 2.79
Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies. Scand J Immunol (1976) 2.78
Immune response after splenectomy. Lancet (1978) 2.31
Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. Lancet (1981) 2.29
Postsplenectomy sepsis. Perspect Pediatr Pathol (1973) 2.19
Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1. Biochemistry (1980) 1.80
Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin Exp Immunol (1984) 1.79
The syndrome of asplenia, pneumococcal sepsis, and disseminated intravascular coagulation. Ann Intern Med (1970) 1.66
Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains. Immunology (1981) 1.65
Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med (1981) 1.65
Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types. Infect Immun (1983) 1.46
Hyposplenism and overwhelming pneumococcal infection: a reappraisal. Am J Med Sci (1971) 1.36
The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity. J Immunol Methods (1984) 1.21
Selective depression of thymus-independent anti-DNP antibody responses induced by adult but not neonatal splenectomy. Clin Exp Immunol (1985) 1.10
Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children. Acta Paediatr Scand (1982) 1.08
Subpopulations of antibodies to phosphocholine in human serum. J Immunol (1984) 1.04
Vaccine-type pneumococcal pneumonia. Occurrence after vaccination in an asplenic patient. JAMA (1979) 0.95
Antibody response to pneumococcal vaccine in splenectomized adults and adolescents. Acta Pathol Microbiol Immunol Scand C (1982) 0.89
Immunologic memory to phosphorylcholine in vitro. I. Asymmetric expression of clonal dominance. J Immunol (1981) 0.87
Antibody response and opsonization afer pneumococcal vaccination in splenectomized children and healthy persons. Acta Pathol Microbiol Immunol Scand C (1982) 0.87
Failure of pneumococcal vaccination in a splenectomized child. Acta Paediatr Scand (1982) 0.79
Outcome and sepsis after splenectomy in adults. Am J Surg (1982) 0.79
Immunological memory and protective immunity: understanding their relation. Science (1996) 10.02
Mice lacking MHC class II molecules. Cell (1991) 6.25
Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol (1991) 5.38
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev (1972) 4.79
Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J (1994) 4.40
Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32
A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes. Immunology (1969) 3.12
Antigen-driven selection of virgin and memory B cells. Immunol Rev (1986) 3.10
Effect of specific antibody to target cells on their specific and non-specific interactions with lymphocytes. Nature (1968) 2.96
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (1987) 2.96
Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nat Immunol (2001) 2.83
Competition for receptors for immunoglobulin on cytotoxic lymphocytes. Clin Exp Immunol (1972) 2.77
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol (1991) 2.71
Do women with acute myocardial infarction receive the same treatment as men? BMJ (1994) 2.70
Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science (1992) 2.60
Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol (1992) 2.54
Screening and the 1990 contract. BMJ (1990) 2.52
Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache (2000) 2.50
Germinal centres in T-cell-dependent antibody responses. Immunol Today (1992) 2.47
Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes. Cell Calcium (2000) 2.32
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart (1999) 2.31
Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol (1988) 2.26
Germinal centers without T cells. J Exp Med (2000) 2.25
CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature (1995) 2.23
Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med (1996) 2.18
Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of human ehrlichiosis, in dogs from southeast Virginia. Am J Vet Res (1996) 2.17
B cells solicit their own help from T cells. J Exp Med (1996) 2.16
Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine. J Chromatogr B Biomed Sci Appl (2000) 2.16
Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol (1981) 2.08
Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ (1997) 2.08
Indigenous Australians and liquor licensing restrictions. Addiction (2000) 2.03
Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol (1971) 2.02
The evolution of B-cell clones. Curr Top Microbiol Immunol (1990) 1.97
The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. II. The mechanism of target cell damage by lymphoid cells from immunized rats. Immunology (1970) 1.96
T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med (1998) 1.91
Distinct short-lived and long-lived antibody-producing cell populations. Eur J Immunol (1986) 1.89
Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis (1999) 1.88
Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med (2000) 1.87
Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A (2007) 1.86
Melanomas in renal transplant recipients. Br J Dermatol (2006) 1.85
Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol (1991) 1.82
Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrob Agents Chemother (2001) 1.81
Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80
Statin prescribing in Nottingham general practices: a cross-sectional study. J Public Health Med (1999) 1.77
Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem (1990) 1.77
CD23: a multi-functional receptor/lymphokine? Immunol Today (1989) 1.76
Resuscitation from out-of-hospital cardiac arrest: is survival dependent on who is available at the scene? Heart (1999) 1.76
Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group. Int J Cancer (1979) 1.75
Use of statins in general practices, 1996-8: cross sectional study. BMJ (2000) 1.73
Behaviour problems in pre-school children. J Child Psychol Psychiatry (1980) 1.72
Migrant mu+ delta+ and static mu+ delta- B lymphocyte subsets. Eur J Immunol (1982) 1.71
Management of hypertension and the core services guidelines: results from interviews with 100 Auckland general practitioners. N Z Med J (1995) 1.70
Follicular dendritic cell-dependent adhesion and proliferation of B cells in vitro. J Immunol (1992) 1.69
Efficacy of breathing and coughing exercises in the prevention of pulmonary complications after coronary artery surgery. Chest (1994) 1.66
Public health improvement in Iran--lessons from the last 20 years. Public Health (2004) 1.64
Failure of certain cytotoxic lymphocytes to respond mitotically to phytohaemagglutinin. Nature (1970) 1.62
Inactivation of oriented bacteria with polarized ultraviolet light. Biophys J (1965) 1.61
A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med (1995) 1.60
Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J Exp Med (1997) 1.57
Using telecommunication technology to manage children with diabetes: the Computer-Linked Outpatient Clinic (CLOC) Study. Diabetes Educ (1995) 1.56
Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. Br Med J (1973) 1.50
Changes in the process of care for Medicaid patients with schizophrenia in Utah's Prepaid Mental Health Plan. Psychiatr Serv (1998) 1.49
ACE inhibitors for myocardial infarction and unstable angina. Lancet (1993) 1.47
Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J Exp Med (1997) 1.46
The effect of peripheral lymphocytes from patients with inflammatory joint disease on human target cells in vitro. Clin Exp Immunol (1968) 1.46
Identifying the risk of death following hospital discharge in patients admitted with a suspected acute myocardial infarction in whom the diagnosis is not confirmed. Eur Heart J (2000) 1.46
The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival. Q J Med (1991) 1.45
Who cares for young carers? BMJ (1994) 1.45
Dendritic cells associated with plasmablast survival. Eur J Immunol (1999) 1.44
Effect of gender on outcomes following renal artery stent placement for renovascular hypertension. Cathet Cardiovasc Diagn (1997) 1.43
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol (1973) 1.41
Inhibitory effect of rheumatoid sera on cell damage by lymphocytes. Ann Rheum Dis (1972) 1.40
Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab (1990) 1.40
Manipulation of substrate utilization with somatostatin in patients with secondary multiple organ dysfunction syndrome. Crit Care Med (1995) 1.40
Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol (1974) 1.39
T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur J Immunol (1999) 1.39
Cellular interactions involved in Th cell memory. J Immunol (2000) 1.38
Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons. Br J Pharmacol (2009) 1.38
Target-controlled infusions. Anaesthesia (1999) 1.38
Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur J Immunol (2001) 1.38
Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother (1999) 1.38
Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. Anaerobe (2011) 1.36
Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors. Eur J Immunol (1981) 1.36
Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG. Immunology (1974) 1.36
Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development. J Immunol (1999) 1.36
Absorption and attenuation of visible and near-infrared light in water: dependence on temperature and salinity. Appl Opt (1997) 1.35
The IgG subclass responses of human lymphocytes to B-cell activators. Immunology (1983) 1.35
Formaldehyde in the home--some environmental disease perspectives. Minn Med (1980) 1.33
Utility of SHIV for testing HIV-1 vaccine candidates in macaques. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.32
Differences in the recruitment of virgin B cells into antibody responses to thymus-dependent and thymus-independent type-2 antigens. Eur J Immunol (1986) 1.31
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults. Br J Haematol (1998) 1.30
Newly produced virgin B cells migrate to secondary lymphoid organs but their capacity to enter follicles is restricted. Eur J Immunol (1987) 1.30